Table 1 Clinicopathological features of 346 ovarian cancer (OV) patients

Age (years)

56.18 ± 9.52

59.19 ± 11.13

0.060

Tumor size (cm)

7.75 ± 4.51

7.65 ± 4.89

0.559

Tumor side, n (%)

0.000

 Unilateral

87 (72.5%)

99 (44.0%)

−

 Bilateral

33 (27.5%)

127 (56.0%)

−

Pathological grade, n (%)

0.886

 G1–2

23 (19.2%)

42 (18.6%)

−

 G3

97 (80.8%)

184 (81.4%)

−

Clinical stage, n (%)

0.000

 I–II

75 (62.5%)

55 (24.3%)

−

 III–IV

45 (37.5%)

171 (75.7%)

−

Histological type, n (%)

0.003

 Serous

73 (60.8%)

177 (78.3%)

−

 Mucinous

4 (3.3%)

8 (3.5%)

−

 Endometrioid

18 (15.0%)

14 (6.2%)

−

 Others

25 (20.8%)

27 (11.9%)

−

Ascites, n (%)

0.000

  < 500 ml

98 (81.7%)

121 (53.5%)

−

  > 500 ml

22 (18.3%)

105 (46.5%)

−

 CA-125 (U/mL)

552.17 ± 844.30

1403.96 ± 1784.31

0.000

 Fibrinogen (g/L)

3.45 ± 1.43

4.49 ± 2.35

0.002

 APTT (s)

27.51 ± 6.43

26.93 ± 7.34

0.148

 PT (s)

13.23 ± 10.35

12.23 ± 4.37

0.029

 TT (s)

16.40 ± 2.01

15.37 ± 2.79

0.005

 INR

1.01 ± 0.13

0.89 ± 0.20

0.000

F-INR, n (%)

0.000

 F-INR = 0

92 (76.7%)

85 (37.6%)

−

 F-INR = 1

28 (23.3%)

108 (47.8%)

−

 F-INR = 2

0 (0.00%)

33 (14.6%)

−